Value in, value out
With a greater focus on accelerating development timelines, investors are expecting quicker returns. How can we accelerate products to deliver maximum value for patients and investors?
FACILITATED BY
KATH MACKAY | Director of Life Sciences | Bruntwood SciTech – Alderley Park
PANELLISTS INCLUDE
ANDY HILL | Chief Executive Officer | Nu-Vision Biotherapies
KOUJIRO TAMBARA | Principal | Downing
LOUWAI MUHAMMED | CEO and Co-Founder | CoSyne Therapeutics
CLARE TRIPPETT | Chief Technologist – Biologics | CPI
MARTIN DOORBAR | Chief Development Officer; Non Clinical | Ellipses
JAMIE UNWIN | Commercial Insight Officer | Nanoform